First Trust NYSE Arca Biotechnology Index Fund
189 hedge funds and large institutions have $2.25B invested in First Trust NYSE Arca Biotechnology Index Fund in 2018 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 83 increasing their positions, 26 reducing their positions, and 18 closing their positions.
219% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 26
209% more capital invested
Capital invested by funds: $726M → $2.25B (+$1.52B)
183% more first-time investments, than exits
New positions opened: 51 | Existing positions closed: 18
80% more funds holding in top 10
Funds holding in top 10: 5 → 9 (+4)
69% more call options, than puts
Call options by funds: $2.88M | Put options by funds: $1.71M
40.17% more ownership
Funds ownership: 54.06% → 94.23% (+40%)
20% more funds holding
Funds holding: 157 → 189 (+32)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$676M |
| 2 |
CM
Churchill Management
Los Angeles,
California
|
+$285M |
| 3 |
Morgan Stanley
New York
|
+$87M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$51.9M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$38.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWM
Cornerstone Wealth Management
St. Peters,
Missouri
|
-$7.62M |
| 2 |
SG Americas Securities
New York
|
-$2.86M |
| 3 |
MIAN
Mariner Independent Advisor Network
Overland Park,
Kansas
|
-$1.84M |
| 4 |
Envestnet Asset Management
Chicago,
Illinois
|
-$1.66M |
| 5 |
Wolverine Trading
Chicago,
Illinois
|
-$1.53M |
FBT Hedge Fund Activity: Q3 2018 in Review
189 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2018, worth a combined $2.25B — up 209% from $726M a quarter earlier.
Buyers outnumbered sellers: 51 funds opened new FBT positions and 18 closed out — a net gain of 33 holders — while 83 added to existing stakes and 26 trimmed.
The largest buyer was First Trust Advisors, opening a new position worth an estimated $676M. The largest seller was Cornerstone Wealth Management, exiting entirely with an estimated $7.62M sold.
- 189 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2018, up from 157 in Q2 2018.
- Funds reported $2.25B of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2018, up 209% quarter-over-quarter.
- 51 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2018 and 18 closed out, a net change of +33 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2018 was First Trust Advisors, an estimated $676M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2018 was Cornerstone Wealth Management, an estimated $7.62M sold.
Based on aggregated 13F filings for Q3 2018.